The Possible Effects of Dapagliflozin on 12-derived Electrocardiogram in Patients with Type 2 Diabetes Mellitus


Akkus O., Akkus G., Kaypakli O.

ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, cilt.19, ss.207-213, 2019 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 19 Konu: 2
  • Basım Tarihi: 2019
  • Doi Numarası: 10.2174/1871530319666181218121508
  • Dergi Adı: ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS
  • Sayfa Sayıları: ss.207-213

Özet

Background: Dapagliflozin, sodium glucose cotransporter 2 inhibitor, has potential side effects on electrolyte imbalance as it has diuretic effects which include decreasing glucose reabsorption, increasing glucosuria and natriuresis. We aimed to determine the possible effects of dapagliflozin on electrocardiogram (ECG) in patients with type 2 DM.